Literature DB >> 7060025

Elevated level of enzymatic DNA methylation in cells treated with 1-beta-D-arabinofuranosylcytosine.

T L Boehm, D Drahovsky.   

Abstract

When mouse P815 mastocytoma cells are cultured in the presence of 1-beta-D-arabinofuranosylcytosine (ara-C), a dose-dependent inhibition of cell proliferation and DNA synthesis can be observed. The DNA synthesized in the presence of ara-C is more highly enzymatically methylated than that of controls as measured by conversion of incorporated [14C]deoxycytidine-derived radioactivity into 5-methylcytosines. Analysis of DNAs by means of the bacterial restriction enzyme HpaII and its isoschizomer MspI revealed an aberrant DNA methylation pattern after ara-C treatment. The hypermethylation of DNA persisted also in the cell cycle following the treatment in the absence of ara-C. No such changes in DNA methylation patterns following ara-C treatment were observed in P815/ara-C, a subclone of P815 cells resistant to ara-C.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060025

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Modulation of cytosine arabinoside-induced proliferation inhibition by exogenous adenosylmethionine.

Authors:  E Rakasz; J Sugar; O Csuka
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens.

Authors:  P Fuschiotti; M C Fioretti; L Romani; P Puccetti
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 3.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.

Authors:  T J McMillan; I R Hart
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

5.  Synchronisation by hydroxyurea does not affect the sensitivity of CEM-C7 lymphoblasts to glucocorticoids.

Authors:  F Maehira; R M Gledhill; A J Edwards; M R Norman
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

6.  Sequential treatment with cytarabine and decitabine has an increased anti-leukemia effect compared to cytarabine alone in xenograft models of childhood acute myeloid leukemia.

Authors:  Sarah M Leonard; Tracey Perry; Ciarán B Woodman; Pamela Kearns
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.